INS and Hyperglycemia: Mechanistically, FOXA1 deficiency leads to increased expression of uncoupling protein 2, which partially uncouples mitochondrial oxidative phosphorylation, further affecting the subsequent ATP-dependent closure of potassium channels and inward flow of calcium ions, ultimately inhibiting insulin release and leading to hyperglycemia [36, 37].